Glucocorticoid Receptor 

 186 Products   186 Products   1696 Diseases   95004 News 


«12...299300301302303304305306307308309...10661067»
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Review, Journal:  Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression. (Pubmed Central) -  Jun 29, 2022   
    In addition, experiences using GC targeting therapeutic options (already used and investigated in preclinical and clinical trials), such as classic GC dexamethasone, selective glucocorticoid receptor agonists and modulators, the GC antagonist mifepristone, and GR coregulators, are also summarized. Evidence presented can aid a better understanding of the biology of context-dependent GC action that can lead to further advances in the personalized therapy of breast cancer by the evaluation of GR along with the conventional estrogen receptor (ER) and progesterone receptor (PR) in the routine diagnostic procedure.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy. (Pubmed Central) -  Jun 29, 2022   
    And EVs-Cas9-29b introduced in vivo preserved muscle function in the well-established immobilization and denervation-induced muscle atrophy mice model. Our work demonstrates an engineered extracellular vesicles delivery of the miR-29b editing system, which could be potentially used for muscle atrophy therapy.
  • ||||||||||  Darzalex (daratumumab) / J&J
    New P3 trial:  A Study of Daratumumab (clinicaltrials.gov) -  Jun 28, 2022   
    P3b,  N=400, Not yet recruiting, 
  • ||||||||||  methylprednisolone acetate / Generic mfg.
    New P4 trial:  Pain Increases After Shoulder Injection (clinicaltrials.gov) -  Jun 28, 2022   
    P4,  N=400, Enrolling by invitation, 
  • ||||||||||  Actemra IV (tocilizumab) / Roche, JW Pharma
    Journal:  EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. (Pubmed Central) -  Jun 28, 2022   
    The efficacy of glucocorticoids in cases requiring oxygen therapy suggests that immunomodulatory treatment might be effective in COVID-19 subsets. Involvement of rheumatologists, as systemic inflammatory diseases experts, should continue in ongoing clinical trials delineating optimal immunomodulatory therapy utilisation in COVID-19.
  • ||||||||||  dexamethasone / Generic mfg.
    Review, Journal:  Postoperative adrenal insufficiency in Conn's syndrome-does it occur frequently? (Pubmed Central) -  Jun 28, 2022   
    Postsurgical cortisol values were not different among subjects with or without abnormal dexamethasone suppression test or elevated urinary free cortisol pre-surgery, and were significantly higher in subjects with abnormal diurnal cortisol variability compared with subjects with normal diurnal variability...In conclusion, postoperative cortisol values did not indicate any suspicion of possible adrenal insufficiency. To exclude possible adrenal insufficiency, it may be sufficient to measure morning cortisol in the early postoperative course.
  • ||||||||||  hydrocortisone / Generic mfg., methylprednisolone sodium succinate / Generic mfg.
    Clinical, Journal:  Gynaecomastia and adipomastia on black skin: Clinical and surgical particularity (Pubmed Central) -  Jun 28, 2022   
    Surgical difficulties on black skin are not only technical, but also scarring: hypertrophy and keloids. A delay in surgical management after 30years, and the prevention of unsightly scars would be a track for improving the aesthetic result.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery. (Pubmed Central) -  Jun 28, 2022   
    However, unlike dexamethasone and S100A9 inhibitor, RAGE inhibition did not diminish the efficacy of anti-PD-1 immunotherapy in glioma-bearing mice. These observations confirm the role of the RAGE axis in surgically induced neuroinflammation and provide an alternative therapeutic option to dexamethasone in managing post-operative cerebral edema.
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    Journal:  Refractory IgG4-Related Disease Complicated with Organizing Pneumonia and Hypertrophic Pachymeningitis. (Pubmed Central) -  Jun 28, 2022   
    The diagnosis was confirmed based on the serum concentration of IgG4 and the results of salivary gland and transbronchial lung biopsies. HP did not respond to steroid monotherapy and was also resistant to rituximab and intravenous cyclophosphamide; however, the combination therapy of methotrexate and dexamethasone was effective.
  • ||||||||||  selisistat (SEN-196) / AOP Orphan Pharma
    Journal:  STK11 overexpression prevents glucocorticoid-induced osteoporosis via activating the AMPK/SIRT1/PGC1α axis. (Pubmed Central) -  Jun 28, 2022   
    An in-vitro OP model was induced by dexamethasone (DEX)...The SIRT1 inhibitor EX-527, PGC1α inhibitor SR-18292, and AMPK activator metformin were administered into hMSCs for confirming the mechanism of SKT11...Inhibiting SIRT1 or PGC1α repressed the promotive effect of STK11 on osteogenic differentiation of hMSCs, while activation of AMPK abated the inhibitory effect of STK11 knockdown on osteogenic differentiation of hMSCs. In conclusion, this study revealed that overexpressing STK11 dampened GC-induced OP by activating the AMPK/SIRT1/PGC1α axis.
  • ||||||||||  triamcinolone acetonide / Generic mfg.
    Journal:  Stellate Hypopigmentation in a Pediatric Patient After Treatment with Intralesionally-Injected Corticosteroid. (Pubmed Central) -  Jun 28, 2022   
    One of the most widely used treatment modalities for keloidal scars involves the intralesional injection of corticosteroids, such as triamcinolone acetonide (TAC)...Although previous reports of corticosteroid injections' adverse effects resulting in hypopigmentation have been published, this condition is uncommon or poorly reported in pediatric patients. This report aims to contribute to our understanding of the effects of administering corticosteroids in pediatric patients by virtue of diversifying the cases reported in the currently available literature.
  • ||||||||||  Lysodren (mitotane) / HRA Pharma
    Journal:  Massive adrenocortical carcinoma presenting as peripheral edema: a case report. (Pubmed Central) -  Jun 28, 2022   
    Advanced stages of adrenocortical carcinoma are associated with poor prognosis. Mitotane chemotherapy is a standard but unproven adjuvant treatment that is associated with many complications, and its induction of hepatic CYP 3A4 enzymes necessitates adjustment of other medications.
  • ||||||||||  prednisolone / Generic mfg.
    Journal:  T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis. (Pubmed Central) -  Jun 28, 2022   
    Participants with definite or probable TBP were randomly assigned to receive five injections of MIP or placebo at 2-week intervals and either 6 weeks of oral prednisolone or placebo...Despite the positive effect of prednisolone on hospitalizations and constrictive pericarditis in the IMPI trial, prednisolone did not significantly reduce pro-inflammatory T cell responses in this sub-study. The modest improvement of mycobacteria-specific T cell upon combinatorial therapy with MIP and prednisolone requires further investigation.
  • ||||||||||  Triesence (triamcinolone acetonide injectable suspension) / Novartis
    Retrospective data, Journal:  Clinical Study of Intravitreal Injection of Anti-VEGF Drugs Combined with Triamcinolone Acetonide in the Treatment of Coats Disease. (Pubmed Central) -  Jun 28, 2022   
    The effective rate of 95.56% in the treatment group was significantly higher than that of 86.67% in the control group, and the complication rate was significantly lower than that of the control group, with statistically significant differences (P < 0.05). Intravitreal injection of anti-VEGF drugs combined with tretinoin injection can significantly improve the clinical efficacy of patients with Coats disease and improve visual acuity and central retinal thickness, which has certain reference value for the clinical treatment of Coats disease.
  • ||||||||||  dexamethasone / Generic mfg.
    Preclinical, Journal:  Human Placental Mesenchymal Stem Cells for the Treatment of ARDS in Rat. (Pubmed Central) -  Jun 28, 2022   
    The rats were randomly divided into five groups: I: LPS, II: LPS+dexamethasone, III: LPS+HPMSCs, IV: HPMSC, and V: saline...At the same time, a huge number of MSCs can be obtained from the placental tissue, and there is no ethical controversy around their use. The freeze-dried MSCs from human placental tissue can be stored sterile at room temperature for a long time before use.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Sex Differences in Hypercortisolism and Glucose-Metabolism Disturbances in Patients with Mild Autonomous Cortisol Secretion: Findings From a Single Center in China. (Pubmed Central) -  Jun 28, 2022   
    Cortisol levels at 00:00 and 08:00 h after a 1-mg dexamethasone suppression test (DST) and low-dose DST were significantly higher in female than in male MACS patients, and the inhibition rate of 1-mg DST was lower in the women than in the men...The level of autonomic cortisol secretion in female patients with MACS was higher than in male patients, and the association between autonomous cortisol secretory ability and glucose homeostasis was only noted in patients with autonomous cortisol secretion and in premenopausal women. This phenomenon will, however, require closer follow-up.
  • ||||||||||  hydrocortisone / Generic mfg.
    Retrospective data, Journal:  Genotype, Mortality, Morbidity, and Outcomes of 3β-Hydroxysteroid Dehydrogenase Deficiency in Algeria. (Pubmed Central) -  Jun 28, 2022   
    Mortality is also high, with significant morbidity from adrenal tumors and PCOS in adolescence and an increased risk of learning disability. The finding of adrenal tumors in older patients with 3βHSD2 indicates under-replacement, requiring effective hydrocortisone and fludrocortisone treatment rather than surgical removal.
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD), Oncaspar liquid (pegaspargase) / Servier
    Trial completion:  NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma (clinicaltrials.gov) -  Jun 28, 2022   
    P2,  N=23, Completed, 
    The finding of adrenal tumors in older patients with 3βHSD2 indicates under-replacement, requiring effective hydrocortisone and fludrocortisone treatment rather than surgical removal. Active, not recruiting --> Completed
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD)
    Enrollment open, Trial completion date, Trial primary completion date:  Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma (clinicaltrials.gov) -  Jun 28, 2022   
    P2,  N=40, Recruiting, 
    Active, not recruiting --> Completed Unknown status --> Recruiting | Trial completion date: Jan 2022 --> Jan 2023 | Trial primary completion date: Jan 2022 --> Jan 2023
  • ||||||||||  dexamethasone / Generic mfg., everolimus / Generic mfg., sirolimus / Generic mfg.
    The mTOR pathway regulates glucose-6-phosphate dehydrogenase expression and redox balance in T-cell acute lymphoblastic leukemia cells (Poster Area) -  Jun 28, 2022 - Abstract #EACR2022EACR_903;    
    S tudies of PDX-inoculated mice confirmed that everolimus could overcome dexamethasone resistance in conditions of high tumor burden that mimicked the clinical setting of acute leukemia. Conclusion These findings identify a link between mTOR pathway activation, G6PD expression, and ROS homeostasis in T-ALL cells and furnish mechanistic evidence to support the combination of glucocorticoids with mTOR inhibitors to treat GC-resistant T-ALL.
  • ||||||||||  dexamethasone / Generic mfg.
    Right on time to defeat cancer: investigating the connection between the circadian rhythm and lung tumorigenesis. (Poster Area) -  Jun 28, 2022 - Abstract #EACR2022EACR_369;    
    Cells were transduced with Bmal1-luciferase (luc) and Per2-luc lentivectors, synchronized in vitro with dexamethasone, and circadian bioluminescence was recorded at population and single cell levels...Our data showed suppressed cancer cell growth following clock disruption and identified core-clock components as novel promising therapeutic targets. Further mechanistic studies in cell lines, as well as the characterization of core-clock component changes in primary lung cancer cells established from patient biopsies will have direct implications for current efforts on identifying novel therapeutic targets and on improving the diagnosis of these malignancies.
  • ||||||||||  hydrocortisone / Generic mfg.
    Trial initiation date:  Imaging CRF X NOP Interactions in CUD (clinicaltrials.gov) -  Jun 28, 2022   
    P1,  N=80, Recruiting, 
    Further mechanistic studies in cell lines, as well as the characterization of core-clock component changes in primary lung cancer cells established from patient biopsies will have direct implications for current efforts on identifying novel therapeutic targets and on improving the diagnosis of these malignancies. Initiation date: Sep 2021 --> Jun 2019
  • ||||||||||  Agamree (vamorolone) / Santhera
    Enrollment open:  A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD) (clinicaltrials.gov) -  Jun 28, 2022   
    P2,  N=39, Recruiting, 
    Trial completion date: Sep 2023 --> Apr 2024 | Trial primary completion date: Dec 2022 --> Jul 2023 Not yet recruiting --> Recruiting
  • ||||||||||  bortezomib / Generic mfg., dexamethasone / Generic mfg., pomalidomide / Generic mfg.
    New P2 trial:  PVd Versus Vd in NDMM Patients With RI (clinicaltrials.gov) -  Jun 26, 2022   
    P2,  N=79, Not yet recruiting, 
  • ||||||||||  Trelegy Ellipta (fluticasone furoate/umeclidinium bromide/vilanterol) / GSK, Innoviva, Theravance Biopharma
    CAPTAIN study: Effects of baseline IgE levels on triple therapy response in inadequately controlled asthma (Ponce Foyer) -  Jun 26, 2022 - Abstract #EAC2022EAC_15;    
    P3
    Effects of adding UMEC and/or increasing FF dose according to IgE levels were generally consistent with the overall population. Although eosinophils and IgE levels are associated with type-2 inflammation, their influence on treatment response differs; unlike eosinophils, baseline IgE levels do not appear to predict treatment response.
  • ||||||||||  Trelegy Ellipta (fluticasone furoate/umeclidinium bromide/vilanterol) / GSK, Innoviva, Theravance Biopharma
    CAPTAIN: Relationship between FEV1 reversibility at screening as a continuous variable and treatment response (Ponce Foyer) -  Jun 26, 2022 - Abstract #EAC2022EAC_13;    
    P3
    Improvements in lung function were largely independent of FEV1 reversibility at screening, with greater improvements observed following UMEC addition. Increasing FF dose led to a reduction in moderate/severe exacerbation rates independently of FEV1 reversibility at screening, whereas adding UMEC had a minimal effect.
  • ||||||||||  fluticasone / Generic mfg.
    Rationale and Design for Randomized, Double-Blind, EDS-Placebo–Controlled Trials of EDS-FLU in Chronic Rhinosinusitis (Ponce Foyer) -  Jun 26, 2022 - Abstract #EAC2022EAC_1;    
    In the absence of a standardized drug development pathway for CRS, a panel of experts developed a novel study design for the exhalation delivery system with fluticasone (EDS-FLU) that meets the criteria set forth in prior FDA draft guidance and is feasible to conduct and generalizable to the CRS population... Thoughtful preparation, input from FDA, and applying an iterative process yielded a novel study design for testing CRS therapies.